- Home
- CPS vs PRME Comparison
CPS vs PRME Comparison
Compare CPS & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPS | PRME |
|---|---|---|
| Founded | 1960 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.2M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CPS | PRME |
|---|---|---|
| Price | $47.66 | $3.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $39.00 | $6.42 |
| AVG Volume (30 Days) | 210.7K | ★ 2.8M |
| Earning Date | 02-12-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,740,915,000.00 | $5,977,000.00 |
| Revenue This Year | $6.50 | $95.64 |
| Revenue Next Year | $5.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.37 | ★ 647.13 |
| 52 Week Low | $10.38 | $1.11 |
| 52 Week High | $47.77 | $6.94 |
Technical Indicators
Market Signals| Indicator | CPS | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 80.57 | 39.16 |
| Support Level | $33.92 | $3.20 |
| Resistance Level | $36.60 | $3.50 |
| Average True Range (ATR) | 2.45 | 0.28 |
| MACD | 1.30 | -0.06 |
| Stochastic Oscillator | 87.48 | 10.04 |
Price Performance
Historical ComparisonAbout CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.